219 related articles for article (PubMed ID: 25789628)
21. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
Kazankov K; Tordjman J; Møller HJ; Vilstrup H; Poitou C; Bedossa P; Bouillot JL; Clement K; Grønbaek H
J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
[TBL] [Abstract][Full Text] [Related]
22. Expression of CD206 and CD163 on intermediate CD14
Li X; Du N; Xu G; Zhang P; Dang R; Jiang Y; Zhang K
Virus Res; 2018 Jul; 253():92-102. PubMed ID: 29857122
[TBL] [Abstract][Full Text] [Related]
23. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Ishida C; Tanaka S; Morishima T; Ichiyama T
Brain Dev; 2013 Aug; 35(7):626-9. PubMed ID: 23149357
[TBL] [Abstract][Full Text] [Related]
24. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
Nunes PR; Romão-Veiga M; Peraçoli JC; Araujo Costa RA; de Oliveira LG; Borges VTM; Peraçoli MT
Immunol Res; 2019 Jun; 67(2-3):194-201. PubMed ID: 31240481
[TBL] [Abstract][Full Text] [Related]
26. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
Fabriek BO; Møller HJ; Vloet RP; van Winsen LM; Hanemaaijer R; Teunissen CE; Uitdehaag BM; van den Berg TK; Dijkstra CD
J Neuroimmunol; 2007 Jul; 187(1-2):179-86. PubMed ID: 17537523
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD163.
Møller HJ
Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
30. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.
Ingels C; Møller HJ; Hansen TK; Wouters PJ; Vanhorebeek I; Van den Berghe G
J Clin Immunol; 2013 Apr; 33(3):619-29. PubMed ID: 23150181
[TBL] [Abstract][Full Text] [Related]
32. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
33. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O
Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of soluble CD163 as a marker of inflammation in psoriasis.
Feighery C; Dunne J; Bingham EA; Feighery CF
Clin Exp Dermatol; 2011 Mar; 36(2):201-3. PubMed ID: 21323937
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
36. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
Møller HJ; Grønbaek H; Schiødt FV; Holland-Fischer P; Schilsky M; Munoz S; Hassanein T; Lee WM;
J Hepatol; 2007 Nov; 47(5):671-6. PubMed ID: 17629586
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
38. Levels of soluble CD163 and severity of malaria in children in Ghana.
Kusi KA; Gyan BA; Goka BQ; Dodoo D; Obeng-Adjei G; Troye-Blomberg M; Akanmori BD; Adjimani JP
Clin Vaccine Immunol; 2008 Sep; 15(9):1456-60. PubMed ID: 18632918
[TBL] [Abstract][Full Text] [Related]
39. Increased serum levels of soluble CD163 in patients with scleroderma.
Shimizu K; Ogawa F; Yoshizaki A; Akiyama Y; Kuwatsuka Y; Okazaki S; Tomita H; Takenaka M; Sato S
Clin Rheumatol; 2012 Jul; 31(7):1059-64. PubMed ID: 22453843
[TBL] [Abstract][Full Text] [Related]
40. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]